M Odette Gore1, Stephen L Seliger2, Christopher R Defilippi2, Vijay Nambi3, Robert H Christenson4, Ibrahim A Hashim5, Ron C Hoogeveen6, Colby R Ayers7, Wensheng Sun6, Darren K McGuire8, Christie M Ballantyne6, James A de Lemos9. 1. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. 2. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. 3. Department of Medicine, Baylor College of Medicine, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas; Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas. 4. Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland. 5. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas. 6. Department of Medicine, Baylor College of Medicine, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. 7. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. 8. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas. 9. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: James.deLemos@UTSouthwestern.edu.
Abstract
OBJECTIVES: The study sought to determine the 99th percentile upper reference limit for the high-sensitivity cardiac troponin T assay (hs-cTnT) in 3 large independent cohorts. BACKGROUND: The presently recommended 14 ng/l cut point for the diagnosis of myocardial infarction using the hs-cTnT assay was derived from small studies of presumably healthy individuals, with relatively little phenotypic characterization. METHODS: Data were included from 3 well-characterized population-based studies: the Dallas Heart Study (DHS), the Atherosclerosis Risk in Communities (ARIC) Study, and the Cardiovascular Health Study (CHS). Within each cohort, reference subcohorts were defined excluding individuals with recent hospitalization, overt cardiovascular disease, and kidney disease (subcohort 1), and further excluding those with subclinical structural heart disease (subcohort 2). Data were analyzed stratified by age, sex, and race. RESULTS: The 99th percentile values for the hs-cTnT assay in DHS, ARIC, and CHS were 18, 22, and 36 ng/l (subcohort 1) and 14, 21, and 28 ng/l (subcohort 2), respectively. These differences in 99th percentile values paralleled age differences across cohorts. Analyses within sex/age strata yielded similar results between cohorts. Within each cohort, 99th percentile values increased with age and were higher in men. More than 10% of men 65 to 74 years of age with no cardiovascular disease in our study had cardiac troponin T values above the current myocardial infarction threshold. CONCLUSIONS: Use of a uniform 14 ng/l cutoff for the hs-cTnT assay may lead to over-diagnosis of myocardial infarction, particularly in men and the elderly. Clinical validation is needed of new age- and sex-specific cutoff values for this assay.
OBJECTIVES: The study sought to determine the 99th percentile upper reference limit for the high-sensitivity cardiac troponin T assay (hs-cTnT) in 3 large independent cohorts. BACKGROUND: The presently recommended 14 ng/l cut point for the diagnosis of myocardial infarction using the hs-cTnT assay was derived from small studies of presumably healthy individuals, with relatively little phenotypic characterization. METHODS: Data were included from 3 well-characterized population-based studies: the Dallas Heart Study (DHS), the Atherosclerosis Risk in Communities (ARIC) Study, and the Cardiovascular Health Study (CHS). Within each cohort, reference subcohorts were defined excluding individuals with recent hospitalization, overt cardiovascular disease, and kidney disease (subcohort 1), and further excluding those with subclinical structural heart disease (subcohort 2). Data were analyzed stratified by age, sex, and race. RESULTS: The 99th percentile values for the hs-cTnT assay in DHS, ARIC, and CHS were 18, 22, and 36 ng/l (subcohort 1) and 14, 21, and 28 ng/l (subcohort 2), respectively. These differences in 99th percentile values paralleled age differences across cohorts. Analyses within sex/age strata yielded similar results between cohorts. Within each cohort, 99th percentile values increased with age and were higher in men. More than 10% of men 65 to 74 years of age with no cardiovascular disease in our study had cardiac troponin T values above the current myocardial infarction threshold. CONCLUSIONS: Use of a uniform 14 ng/l cutoff for the hs-cTnT assay may lead to over-diagnosis of myocardial infarction, particularly in men and the elderly. Clinical validation is needed of new age- and sex-specific cutoff values for this assay.
Authors: A K Saenger; R Beyrau; S Braun; R Cooray; A Dolci; H Freidank; E Giannitsis; S Gustafson; B Handy; H Katus; S E Melanson; M Panteghini; P Venge; M Zorn; P Jarolim; D Bruton; J Jarausch; A S Jaffe Journal: Clin Chim Acta Date: 2011-01-08 Impact factor: 3.786
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Paul M McKie; Denise M Heublein; Christopher G Scott; Mary Lou Gantzer; Ramila A Mehta; Richard J Rodeheffer; Margaret M Redfield; John C Burnett; Allan S Jaffe Journal: Clin Chem Date: 2013-04-16 Impact factor: 8.327
Authors: Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Anna Fretz; Andrea L C Schneider; John W McEvoy; Ron Hoogeveen; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin Journal: Am J Epidemiol Date: 2016-02-08 Impact factor: 4.897
Authors: Alexandra K Lee; John W McEvoy; Ron C Hoogeveen; Christie M Ballantyne; Elizabeth Selvin Journal: J Am Coll Cardiol Date: 2016-09-20 Impact factor: 24.094
Authors: A Duma; C Wagner; M Titz; M Maleczek; M Hüpfl; V B Weihs; E Samaha; H Herkner; T Szekeres; M Mittlboeck; M G Scott; A S Jaffe; P Nagele Journal: Br J Anaesth Date: 2017-12-05 Impact factor: 9.166
Authors: Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg Journal: Nat Rev Cardiol Date: 2017-04-06 Impact factor: 32.419
Authors: Elizabeth Selvin; Mariana Lazo; Yuan Chen; Lu Shen; Jonathan Rubin; John W McEvoy; Ron C Hoogeveen; A Richey Sharrett; Christie M Ballantyne; Josef Coresh Journal: Circulation Date: 2014-08-22 Impact factor: 29.690
Authors: Jonathan Rubin; Kunihiro Matsushita; Mariana Lazo; Christie M Ballantyne; Vijay Nambi; Ron Hoogeveen; A Richey Sharrett; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin Journal: Clin Biochem Date: 2016-03-11 Impact factor: 3.281